The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Interferon-α Treatment of Four Patients with the Churg-Strauss Syndrome
Abstract
BACKGROUND: Interferon-alpha is reported to have a beneficial effect on patients with the idiopathic hypereosinophilic syndrome. OBJECTIVE: To study the effect of interferon-alpha on the Churg-Strauss syndrome. DESIGN: Case series. SETTING: University hospital. PATIENTS: Four patients with biopsy-proven Churg-Strauss syndrome. INTERVENTION: Interferon-alpha at dosages of 7.5 to 63 million U per week. MEASUREMENTS: Disease extent, disease activity, and blood eosinophil count in a treatment period ranging from 14 to 25 months. RESULTS: Interferon-alpha therapy led to remission of disease and a substantial reduction of the prednisolone requirement in two patients who had attained incomplete remission with cyclophosphamide or methotrexate. The third patient's condition stabilized, and the fourth patient maintained remission. During interferon-alpha therapy, the blood eosinophil count in all patients decreased in a dose-dependent manner and paralleled the extent of clinical disease and disease activity. CONCLUSIONS: Interferon-alpha may be an effective treatment for the Churg-Strauss syndrome. It seems to exert its effect primarily by producing a dose-dependent decrease in the blood eosinophil count.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FAUCI, A. S., HARLEY, J. B., ROBERTS, W. C., FERRANS, V. J., GRALNICK, H. R., & BJORNSON, B. H. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-78 · Cited by 823
Cited by
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Sablé-Fourtassou, R., Cohen, P., Mahr, A., Pagnoux, C., Mouthon, L., Jayne, D., Blockmans, D., Cordier, J.-F., Delaval, P., Puechal, X., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00006 · Cited by 688
Noth, I., Strek, M. E., & Leff, A. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12518-4 · Cited by 527
Groh, M., Pagnoux, C., Baldini, C., Bel, E., Bottero, P., Cottin, V., Dalhoff, K., Dunogué, B., Gross, W., Holle, J., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.04.022 · Cited by 476
Self-citationApproaches to the treatment of hypereosinophilic syndromes: A workshop summary report
Klion, A. D., Bochner, B. S., Gleich, G. J., Nutman, T. B., Rothenberg, M. E., Simon, H.-U., Wechsler, M. E., Weller, P. F., & the Hypereosinophilic Syndromes Working Group (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.042 · Cited by 342
Churg–Strauss syndrome: outcome and long‐term follow‐up of 32 patients
Solans, R., Bosch, J. A., Pérez‐Bocanegra, C., Selva, A., Huguet, P., Alijotas, J., Orriols, R., Armadans, L., & Vilardell, M. (2001) · Rheumatology · doi:10.1093/rheumatology/40.7.763 · Cited by 294
Metadata
- Authors
- Tatsis, E., Schnabel, A., & Gross, W. L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1998-09-01
- Volume
- 129
- Issue
- 5
- Pages
- 370-374
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1996493107
- Cited by
- 172
- References
- 1
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon-α Treatment of Four Patients with the Churg-Strauss Syndrome. https://app.cochat.ai/papers/10.7326/0003-4819-129-5-199809010-00004
- The paper
- Tatsis, E., Schnabel, A., & Gross, W. L. (1998). Interferon-α Treatment of Four Patients with the Churg-Strauss Syndrome. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-129-5-199809010-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.